Spontaneous remission of Cushing's disease: A systematic review

被引:6
作者
Popa Ilie, Ioana Rada [1 ]
Maria Herdean, Alina [1 ]
Ioan Herdean, Andrei [2 ]
Emanuela Georgescu, Carmen [1 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Dept Endocrinol, 3-5 Louis Pasteur St, Cluj Napoca 400349, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Dept Anat & Embriol, Cluj Napoca 400006, Romania
关键词
Spontaneous remission; Cushing's disease; Pituitary apoplexy; PITUITARY APOPLEXY; KETOCONAZOLE TREATMENT; TUMOR; PATIENT; ACTH; RECURRENCE; HORMONE; ADENOMA;
D O I
10.1016/j.ando.2021.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Spontaneous remission is rare in Cushing's disease. We describe one illustrative case and provide a sys-tematic review of cases previously reported in the literature. Case report: A 51-year-old woman diagnosed with Cushing's disease underwent 9 months' isolated metyrapone treatment. Two months after end of treatment, she was admitted with acute kidney failure. After another 4 months, in June 2020, there was no evidence of hypercortisolism, either clinically or biochemically, or of hypocortisolism. At the time of writing, 1 year later, she was still in remission. Cases reported in the literature: 23 patients were reported, including the present case. 87% were female with a median age of 32 years. Ten of those with radiologically visible tumors had microadenoma (44%) and 7 had macroadenoma (30%). Mean time from diagnosis to spontaneous remission was 5 months, and was shorter in macroadenoma (1 month) than in microadenoma (13.5 months). Treatments before spontaneous remission were: no treatment (65%), steroidogenesis enzyme inhibitors (22%), bilateral adrenalectomy and adrenal autotransplantation (5%), partial bilateral adrenalectomy (4%), and incomplete pituitary surgery (4%). Pituitary tumor apoplexy was the most frequently incriminated event (91%), radiologically documented in 43% of patients. Mean remission during follow-up was 28 months (range, 6-130 months). Recurrence occurred in 39% (n = 9) of patients. Although several mechanisms responsible for this phenomenon have been proposed, clinical or subclinical pituitary tumor apoplexy, the latter sometimes presenting atypically, seems to be the most frequently incriminated event. Doctors should be aware of this, and regular follow-up is mandatory due to its unpredictability. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:613 / 621
页数:9
相关论文
共 51 条
[1]  
Akl E.A., 2021, Br. Med. J., V372, pn71, DOI [10.1136/bmj.n71, DOI 10.1136/BMJ.N71]
[2]   Repeated remissions of cushing's disease due to recurrent infarctions of an ACTH-Producing pituitary macroadenoma [J].
Alarifi A. ;
Alzahrani A.S. ;
Salam S.A. ;
Ahmed M. ;
Kanaan I. .
Pituitary, 2005, 8 (2) :81-87
[3]  
Barletta C, 1989, Minerva Endocrinol, V14, P137
[4]   Pituitary tumour apoplexy [J].
Capatina, Cristina ;
Inder, Warrick ;
Karavitaki, Niki ;
Wass, John A. H. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (05) :R179-R190
[5]  
Catalino MP, 2021, J NEUROSURG, V135, P152, DOI 10.3171/2020.5.JNS201514
[6]   Silent corticotroph adenomas [J].
Cooper, Odelia .
PITUITARY, 2015, 18 (02) :225-231
[7]   Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) [J].
Correa-Silva, Silvia R. ;
Nascif, Sergio O. ;
Molica, Patricia ;
Sa, Larissa B. P. C. ;
Vieira, Jose G. H. ;
Lengyel, Ana-Maria J. .
CLINICAL ENDOCRINOLOGY, 2010, 72 (01) :70-75
[8]   SPONTANEOUS REMISSION IN CUSHINGS-DISEASE [J].
DICKSTEIN, G ;
SPINDEL, A ;
SHECHNER, C ;
ADAWI, F ;
GUTMAN, H .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) :185-189
[9]   Late complications in remission from Cushing disease - Recurrence of tumor with reinfarction or transformation into a silent adenoma [J].
Dickstein, G ;
Arad, E ;
Shechner, C .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (20) :2377-2380
[10]   Cyclic Cushing's syndrome: An overview [J].
Elvira Albiger, Nora Maria ;
Scaroni, Carla M. ;
Mantero, Franco .
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (08) :1253-1260